TheRepublic.com - Eye health News

Regeneron and Bayer say Eylea meets new study goal

Thu, 06 Jun 2013 15:04:07 -0400

NEW YORK - Regeneron Pharmaceuticals Inc. and Bayer HealthCare said Thursday that their eye drug Eylea met its main goal in a new late-stage clinical trial.

Valeant to buy Bausch + Lomb for $8.7B

Mon, 27 May 2013 13:13:02 -0400

Canadian drugmaker Valeant Pharmaceuticals said Monday that it will pay $8.7 billion to buy Bausch + Lomb, one of the world's best-known makers of contact lenses, in a massive expansion of Valeant's smaller ophthalmology business.

UNMC shows off its new eye institute in Omaha

Wed, 22 May 2013 05:23:42 -0400

OMAHA, Nebraska - The University of Nebraska Medical Center is showing off its new $30 million eye institute.